MRNA · 10-Q · 2026Q2 · Full report

Income Tax Rate Changes

Moderna, Inc. · 2026-07-31 · Importance 56 · Surprise 46

Provision for income taxes increased $8 million, or 114%, in the second quarter of 2026 and $10 million, or 71%, in the first six months. The effective tax rates were negative 1.9% for the quarter and negative 1.1% for the six-month period, compared with negative 0.9% and negative 0.8%, respectively, in 2025. The increases primarily reflected higher taxable income at certain foreign subsidiaries while Moderna recorded a consolidated pretax loss. A global valuation allowance continued to limit recognition of tax benefits from losses.